Ildong Pharmaceutical Co., Ltd. (KRX:249420)

South Korea flag South Korea · Delayed Price · Currency is KRW
36,300
-2,500 (-6.44%)
Last updated: Mar 3, 2026, 3:00 PM KST
213.47%
Market Cap 1.22T
Revenue (ttm) 575.66B
Net Income (ttm) 27.92B
Shares Out 31.51M
EPS (ttm) 980.93
PE Ratio 39.55
Forward PE 28.43
Dividend 200.00 (0.52%)
Ex-Dividend Date Mar 30, 2026
Volume 452,400
Average Volume 424,665
Open 37,200
Previous Close 38,800
Day's Range 36,150 - 39,350
52-Week Range 10,300 - 45,050
Beta 1.07
RSI 45.03
Earnings Date Feb 6, 2026

About Ildong Pharmaceutical

Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-cancer, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, and urogenital system applications. It also provide... [Read more]

Sector Healthcare
Founded 1941
Employees 1,061
Stock Exchange Korea Stock Exchange
Ticker Symbol 249420
Full Company Profile

Financial Performance

In 2024, Ildong Pharmaceutical's revenue was 614.94 billion, an increase of 2.36% compared to the previous year's 600.76 billion. Losses were -4.58 billion, -94.20% less than in 2023.

Financial Statements

News

There is no news available yet.